• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1例食管癌伴多发肺转移患者在支架置入及化疗后行手术切除]

[A Case of Esophageal Cancer with Multiple Lung Metastases Resected after Stent Placement and Chemotherapy].

作者信息

Ogo Taichi, Ishihara Kei, Nishino Masashi, Inokuch Mikito, Sakurai Urara

机构信息

Dept. of Surgery, Musashino Red Cross Hospital.

出版信息

Gan To Kagaku Ryoho. 2023 Sep;50(9):997-999.

PMID:37800296
Abstract

A 70-year-old man was diagnosed with middle and lower thoracic esophageal squamous cell carcinoma. A computed tomography(CT)scan revealed multiple pulmonary metastases. The clinical stage was T3N1M1, Stage Ⅳb. After esophageal stent placement was performed to alleviate strong stenotic symptoms, cisplatin/5-fluorouracil(CDDP/5-FU)therapy was introduced, and 8 courses were completed. Four additional courses of 5-FU monotherapy were then administered. Following systemic chemotherapy, CT scans showed no evidence of lung metastases. About a year after the initial treatment, the patient underwent a thoracoscopic esophagectomy. Postoperatively, he was followed up without treatment and has remained alive for 1 year and 4 months without any recurrence.

摘要

一名70岁男性被诊断为胸段食管中下段鳞状细胞癌。计算机断层扫描(CT)显示多发肺转移。临床分期为T3N1M1,Ⅳb期。在置入食管支架以缓解严重狭窄症状后,采用顺铂/5-氟尿嘧啶(CDDP/5-FU)治疗,共完成8个疗程。随后又给予4个疗程的5-氟尿嘧啶单药治疗。全身化疗后,CT扫描显示无肺转移迹象。初始治疗约一年后,患者接受了胸腔镜下食管切除术。术后,对其进行随访观察,未进行治疗,患者存活至今1年4个月,无任何复发迹象。

相似文献

1
[A Case of Esophageal Cancer with Multiple Lung Metastases Resected after Stent Placement and Chemotherapy].[1例食管癌伴多发肺转移患者在支架置入及化疗后行手术切除]
Gan To Kagaku Ryoho. 2023 Sep;50(9):997-999.
2
[A case of esophageal cancer with lung metastases successfully resected after chemotherapy].
Gan To Kagaku Ryoho. 2014 Nov;41(12):2013-5.
3
[Long-Term Complete Response in Postoperative Multiple Lung and Mediastinal Lymph Node Metastases of Esophageal Cancer Using Systemic Chemotherapy with DCF Treatment - A Case Report].[采用DCF方案全身化疗治疗食管癌术后多发肺及纵隔淋巴结转移的长期完全缓解——病例报告]
Gan To Kagaku Ryoho. 2017 Jan;44(1):75-78.
4
[A case of neuroendocrine cell carcinoma of the esophagus with lung metastases successfully treated with CPT-11/CDDP].[一例食管神经内分泌细胞癌伴肺转移经CPT-11/顺铂成功治疗的病例]
Gan To Kagaku Ryoho. 2013 Nov;40(12):2121-3.
5
[Complete recovery obtained with combined S-1 + CDDP therapy in a patient with multiple lung metastases from esophageal cancer].[一名患有食管癌多发肺转移的患者经S-1联合顺铂治疗后实现完全缓解]
Gan To Kagaku Ryoho. 2007 Nov;34(12):1967-9.
6
Case involving long-term survival after esophageal cancer with liver and lung metastases treated by multidisciplinary therapy: report of a case.多学科治疗食管癌细胞肝肺转移长期生存 1 例报告
Surg Today. 2013 May;43(5):556-61. doi: 10.1007/s00595-012-0240-7. Epub 2012 Jul 1.
7
[A successful resected case of advanced esophageal cancer with early gastric cancer responding to neoadjuvant chemotherapy of docetaxel, CDDP and 5-FU].[一例晚期食管癌合并早期胃癌对多西他赛、顺铂和5-氟尿嘧啶新辅助化疗有效的成功切除病例]
Gan To Kagaku Ryoho. 2012 Apr;39(4):645-8.
8
Investigation of operative outcomes of thoracoscopic esophagectomy after triplet chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for advanced esophageal squamous cell carcinoma.三药化疗(多西他赛、顺铂和氟尿嘧啶)联合胸腔镜食管癌根治术治疗局部晚期食管鳞癌的疗效分析。
Surg Endosc. 2018 Jan;32(1):391-399. doi: 10.1007/s00464-017-5688-5. Epub 2017 Jun 29.
9
[A Case of Long-Term Survival by Multidisciplinary Surgical Treatment for Metastatic Multi-Organ Metastasis after Radical Resection of Esophageal Cancer].[1例食管癌根治术后多器官转移行多学科手术治疗长期生存病例]
Gan To Kagaku Ryoho. 2022 Dec;49(13):1992-1994.
10
A case of early relapsed multiple lung metastases after esophagectomy successfully treated with S-1/cisplatin therapy after docetaxel/5-fluorouracil/cisplatin therapy.
J Med Invest. 2006 Aug;53(3-4):321-4. doi: 10.2152/jmi.53.321.